Affiliation:
1. The MOE Key Laboratory of Standardization of Chinese Medicines and SATCM Key Laboratory of New Resources and Quality Evaluation of Chinese Medicines, Institute of Chinese Materia Medica (ICMM) and Shanghai R&D Center for Standardization of Chinese Medicines Shanghai University of Traditional Chinese Medicine (SHUTCM), 1200 Cailun Road Shanghai 201203 P. R. China
2. Department of Pharmacy Anqing Medical College 1588 Jixianbei Road Anqing 246052 P. R. China
Abstract
AbstractArtemisia annua L. is a Chinese medicinal herb, but the origin of its pharmacological properties, including its anti‐inflammatory activity, remain unknown. In this study, five new monoterpene glycosides (1–5) and two new sesquiterpene glycosides (6 and 7) were isolated from the aqueous extract of the aerial parts of A. annua. The structures of these glycosides were determined using high‐resolution electrospray ionization mass spectrometry, nuclear magnetic resonance spectroscopy, electronic circular dichroism calculations, and chemical hydrolysis methods. The anti‐inflammatory activities of the isolated compounds were evaluated by down‐regulating interleukin‐6 (IL‐6) in lipopolysaccharide‐stimulated RAW 264.7 macrophages. Notably, all the new compounds significantly inhibited the expression of IL‐6 in a dose‐dependent manner.
Subject
Molecular Biology,Molecular Medicine,General Chemistry,Biochemistry,General Medicine,Bioengineering
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献